CCAP
Crescent Capital BDC, Inc.
Asset Management
Market Cap$508M
5Y Perf.+12.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CCAP vs MFIC
Revenue, margins, valuation, and 5-year total return — side by side.
MFIC
MidCap Financial Investment Corporation
Asset Management
Market Cap$1.11B
5Y Perf.+19.5%
CCAP vs MFIC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CCAP | MFIC |
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $508M | $1.11B |
| Revenue (TTM) | $167M | $274M |
| Net Income (TTM) | $66.92B | $33M |
| Gross Margin | — | 83.4% |
| Operating Margin | — | 71.6% |
| Forward P/E | 8.3x | 8.9x |
| Total Debt | $0.00 | $2.00B |
| Cash & Equiv. | $31.50B | $99M |
CCAP vs MFIC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CCAP
MFIC
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Crescent Capital BD… (CCAP) | 100 | 112.1 | +12.1% |
| MidCap Financial In… (MFIC) | 100 | 119.5 | +19.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CCAP vs MFIC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MFIC leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Crescent Capital BDC, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CCAP
Crescent Capital BDC, Inc.
The Banking Pick
CCAP is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.67, yield 0.3%
- Lower volatility, beta 0.67
- Beta 0.67, yield 0.3%
Best for: income & stability and sleep-well-at-night
MFIC
MidCap Financial Investment Corporation
The Banking Pick
MFIC carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 21.2%, EPS growth -46.5%
- 66.7% 10Y total return vs CCAP's 52.3%
- 21.2% NII/revenue growth vs CCAP's 17.4%
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MFIC | 21.2% NII/revenue growth vs CCAP's 17.4% |
| Value | CCAP | Lower P/E (8.3x vs 8.9x) |
| Quality / Margins | MFIC | Efficiency ratio 0.1% vs CCAP's 37.5% (lower = leaner) |
| Stability / Safety | CCAP | Beta 0.67 vs MFIC's 0.75 |
| Dividends | MFIC | 12.6% yield, vs CCAP's 0.3% |
| Momentum (1Y) | MFIC | +13.3% vs CCAP's -1.8% |
| Efficiency (ROA) | MFIC | Efficiency ratio 0.1% vs CCAP's 37.5% |
CCAP vs MFIC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCCAPLAGGINGMFIC
MFICMidCap Financial Inve…
2leads
CCAPCrescent Capital BDC,…
3leads
6 Total Categories
CATEGORYLEADERvs MFICMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CCAP3/3
Valuation MetricsMultiples, price ratios, and targets
CCAP5/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CCAP4/6
Total Returns1Y, 3Y, 5Y total returns with dividends
MFIC6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
MFIC1/1
Income & Cash Flow (Last 12 Months)
CCAP leads this category, winning 3 of 3 comparable metrics.
Income & Cash Flow (Last 12 Months)
MFIC is the larger business by revenue, generating $274M annually — 1.6x CCAP's $167M. CCAP is the more profitable business, keeping 400.0% of every revenue dollar as net income compared to MFIC's 23.0%.
| Metric | CCAPCrescent Capital … | MFICMidCap Financial … |
|---|---|---|
| RevenueTrailing 12 months | $167M | $274M |
| EBITDAEarnings before interest/tax | $27M | $160M |
| Net IncomeAfter-tax profit | $66.9B | $33M |
| Free Cash FlowCash after capex | $63M | $272M |
| Gross MarginGross profit ÷ Revenue | — | +83.4% |
| Operating MarginEBIT ÷ Revenue | — | +71.6% |
| Net MarginNet income ÷ Revenue | +400.0% | +23.0% |
| FCF MarginFCF ÷ Revenue | +44.7% | +36.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +6686.7% | -193.8% |
CCAP leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
CCAP leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 7.6x trailing earnings, CCAP trades at a 57% valuation discount to MFIC's 17.8x P/E.
| Metric | CCAPCrescent Capital … | MFICMidCap Financial … |
|---|---|---|
| Market CapShares × price | $508M | $1.1B |
| Enterprise ValueMkt cap + debt − cash | -$31.0B | $3.0B |
| Trailing P/EPrice ÷ TTM EPS | 7.60x | 17.75x |
| Forward P/EPrice ÷ next-FY EPS est. | 8.34x | 8.89x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 15.82x |
| Price / SalesMarket cap ÷ Revenue | 3.04x | 4.06x |
| Price / BookPrice ÷ Book value/share | 0.00x | 0.86x |
| Price / FCFMarket cap ÷ FCF | 6.80x | 10.98x |
CCAP leads this category, winning 5 of 5 comparable metrics.
Profitability & Efficiency
CCAP leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
CCAP delivers a 9.5% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $3 for MFIC. On the Piotroski fundamental quality scale (0–9), MFIC scores 5/9 vs CCAP's 4/9, reflecting solid financial health.
| Metric | CCAPCrescent Capital … | MFICMidCap Financial … |
|---|---|---|
| ROE (TTM)Return on equity | +9.5% | +2.5% |
| ROA (TTM)Return on assets | +4.1% | +1.0% |
| ROICReturn on invested capital | — | +4.6% |
| ROCEReturn on capital employed | — | +6.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | — | 1.53x |
| Net DebtTotal debt minus cash | -$31.5B | $1.9B |
| Cash & Equiv.Liquid assets | $31.5B | $99M |
| Total DebtShort + long-term debt | $0 | $2.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.68x | 1.63x |
CCAP leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
MFIC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MFIC five years ago would be worth $13,336 today (with dividends reinvested), compared to $13,172 for CCAP. Over the past 12 months, MFIC leads with a +13.3% total return vs CCAP's -1.8%. The 3-year compound annual growth rate (CAGR) favors MFIC at 13.9% vs CCAP's 12.6% — a key indicator of consistent wealth creation.
| Metric | CCAPCrescent Capital … | MFICMidCap Financial … |
|---|---|---|
| YTD ReturnYear-to-date | -0.8% | +8.0% |
| 1-Year ReturnPast 12 months | -1.8% | +13.3% |
| 3-Year ReturnCumulative with dividends | +42.6% | +47.9% |
| 5-Year ReturnCumulative with dividends | +31.7% | +33.4% |
| 10-Year ReturnCumulative with dividends | +52.3% | +66.7% |
| CAGR (3Y)Annualised 3-year return | +12.6% | +13.9% |
MFIC leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — CCAP and MFIC each lead in 1 of 2 comparable metrics.
Risk & Volatility
CCAP is the less volatile stock with a 0.67 beta — it tends to amplify market swings less than MFIC's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MFIC currently trades 89.3% from its 52-week high vs CCAP's 80.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CCAPCrescent Capital … | MFICMidCap Financial … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.67x | 0.75x |
| 52-Week HighHighest price in past year | $17.02 | $13.51 |
| 52-Week LowLowest price in past year | $11.80 | $9.48 |
| % of 52W HighCurrent price vs 52-week peak | +80.8% | +89.3% |
| RSI (14)Momentum oscillator 0–100 | 66.2 | 68.3 |
| Avg Volume (50D)Average daily shares traded | 207K | 1.2M |
Evenly matched — CCAP and MFIC each lead in 1 of 2 comparable metrics.
Analyst Outlook
MFIC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CCAP as "Buy" and MFIC as "Hold". Consensus price targets imply 1.8% upside for CCAP (target: $14) vs -8.9% for MFIC (target: $11). For income investors, MFIC offers the higher dividend yield at 12.58% vs CCAP's 0.33%.
| Metric | CCAPCrescent Capital … | MFICMidCap Financial … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $14.00 | $11.00 |
| # AnalystsCovering analysts | 5 | 14 |
| Dividend YieldAnnual dividend ÷ price | +0.3% | +12.6% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.05 | $1.52 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | +1.7% |
MFIC leads this category, winning 1 of 1 comparable metric.
Key Takeaway
CCAP leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MFIC leads in 2 (Total Returns, Analyst Outlook). 1 tied.
Best OverallCrescent Capital BDC, Inc. (CCAP)Leads 3 of 6 categories
Loading custom metrics...
CCAP vs MFIC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CCAP or MFIC a better buy right now?
For growth investors, MidCap Financial Investment Corporation (MFIC) is the stronger pick with 21.
2% revenue growth year-over-year, versus 17. 4% for Crescent Capital BDC, Inc. (CCAP). Crescent Capital BDC, Inc. (CCAP) offers the better valuation at 7. 6x trailing P/E (8. 3x forward), making it the more compelling value choice. Analysts rate Crescent Capital BDC, Inc. (CCAP) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CCAP or MFIC?
On trailing P/E, Crescent Capital BDC, Inc.
(CCAP) is the cheapest at 7. 6x versus MidCap Financial Investment Corporation at 17. 8x. On forward P/E, Crescent Capital BDC, Inc. is actually cheaper at 8. 3x.
03Which is the better long-term investment — CCAP or MFIC?
Over the past 5 years, MidCap Financial Investment Corporation (MFIC) delivered a total return of +33.
4%, compared to +31. 7% for Crescent Capital BDC, Inc. (CCAP). Over 10 years, the gap is even starker: MFIC returned +66. 7% versus CCAP's +52. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CCAP or MFIC?
By beta (market sensitivity over 5 years), Crescent Capital BDC, Inc.
(CCAP) is the lower-risk stock at 0. 67β versus MidCap Financial Investment Corporation's 0. 75β — meaning MFIC is approximately 12% more volatile than CCAP relative to the S&P 500.
05Which is growing faster — CCAP or MFIC?
By revenue growth (latest reported year), MidCap Financial Investment Corporation (MFIC) is pulling ahead at 21.
2% versus 17. 4% for Crescent Capital BDC, Inc. (CCAP). On earnings-per-share growth, the picture is similar: Crescent Capital BDC, Inc. grew EPS -9. 0% year-over-year, compared to -46. 5% for MidCap Financial Investment Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CCAP or MFIC?
Crescent Capital BDC, Inc.
(CCAP) is the more profitable company, earning 400. 0% net margin versus 23. 0% for MidCap Financial Investment Corporation — meaning it keeps 400. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MFIC leads at 71. 6% versus 0. 0% for CCAP. At the gross margin level — before operating expenses — MFIC leads at 83. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CCAP or MFIC more undervalued right now?
On forward earnings alone, Crescent Capital BDC, Inc.
(CCAP) trades at 8. 3x forward P/E versus 8. 9x for MidCap Financial Investment Corporation — 0. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CCAP: 1. 8% to $14. 00.
08Which pays a better dividend — CCAP or MFIC?
All stocks in this comparison pay dividends.
MidCap Financial Investment Corporation (MFIC) offers the highest yield at 12. 6%, versus 0. 3% for Crescent Capital BDC, Inc. (CCAP).
09Is CCAP or MFIC better for a retirement portfolio?
For long-horizon retirement investors, MidCap Financial Investment Corporation (MFIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
75), 12. 6% yield). Both have compounded well over 10 years (MFIC: +66. 7%, CCAP: +52. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CCAP and MFIC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
MFIC pays a dividend while CCAP does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CCAP: 17.4% · MFIC: 21.2%)Net Margin>
%
(CCAP: 40001.2% · MFIC: 23.0%)P/E Ratio<
x
(CCAP: 7.6x · MFIC: 17.8x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.